Clinical Trials
ONO-4578 + Opdivo + mFOLFOX6 vs SOC in first line treatment of metastatic colon cancer
Disease Type: Colon
A randomized, open label, multicenter, Phase 2 study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo® in combination with mFOLFOX6 and bevacizumab versus standard of care for first-line treatment of non-MSI-H/dMMR, PD-L1 positive advanced colorectal cancer
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville